HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitorsA. Gabrielle J. van der Kraan, Julian M.W. Quinn, Ryan C. Chai et al.|Biochemical Journal|2013Cited by 63
Protein Kinase C Epsilon Deletion in Adipose Tissue, but Not in Liver, Improves Glucose ToleranceAmanda E. Brandon, Carsten Schmitz‐Peiffer, Bing Liao et al.|Cell Metabolism|2018Cited by 63
Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factorsPreetinder P. Singh, J Quinn, A. Gabrielle J. van der Kraan et al.|Biochemical and Biophysical Research Communications|2012Cited by 32
Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent MannerRyan C. Chai, John T. Price, Michelle M. Kouspou et al.|Journal of Biological Chemistry|2014Cited by 26
Abstract 2933: HSP90 inhibiting anti-cancer therapeutics enhance bone loss by increasing osteoclast formation: Mechanism of action.A. Gabrielle J. van der Kraan, John T. Price, Ryan R. Chai et al.|Cancer Research|2013Cited by 0